Latest Breaking News On - Pyramid biosciences - Page 1 : comparemela.com

Miami Cancer Institute publication analyzes r

<p>Researchers from Miami Cancer Institute, part of Baptist Health South Florida, today published a study in <em>Trends in Cancer</em> that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs).</p>

United statesFlorida keysManmeets ahluwaliaAtulyaa khoslaVivek subbiahBayer incyteEli lillyAhmad ozairRoche genentechCaris lifesciencesMohamed goudaFernandez family foundationBoston pharmaceuticalsVarian medical systemsIdera pharmaceuticals incyteNational comprehensive cancer network

Pyramid Biosciences and GeneQuantum Healthcare Announce Preclinical Data for GQ1010, a Potential Best-In-Class TROP2-Targeted Antibody Drug Conjugate, at the 2023 AACR Annual Meeting

/PRNewswire/ Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing transformative medicines for patients.

Qin gangUnited statesYajun sunLaura dicaprioBrian lestiniMcdougall communicationsMerck coAmerican association for cancer researchGenequantum healthcare suzhou coPrnewswire pyramid biosciences incPyramid biosciences incGenequantum healthcareAmerican associationCancer researchAnnual meetingPyramid biosciences

Pyramid Biosciences Expands Oncology Pipeline with In-Licensing of GQ1010, a Potential Best-in-class TROP2 Targeted Antibody Drug Conjugate (ADC), from GeneQuantum Healthcare

Pyramid Biosciences Expands Oncology Pipeline with In-Licensing of GQ1010, a Potential Best-in-class TROP2 Targeted Antibody Drug Conjugate (ADC), from GeneQuantum Healthcare
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Qin gangHong kongBrian lestiniPyramid biosciences incMcdougall communicationsPrnewswire pyramid biosciences incGenequantum healthcare suzhou coGenequantum healthcareGreater chinaChief executive officerPyramid biosciencesBiosciences media inquiriesDougall communications

Revance Therapeutics (RVNC) Appoints Vlad Coric to its Board

Revance Therapeutics (RVNC) Appoints Vlad Coric to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPhil vickersMarkj foleyJessica serraLaurence wattsPhilip vickersSara fahyBristol myers squibbBristol myers squibb companyAvita therapeutics incWake forest university school of medicineUniversity of connecticutOncology global clinical researchRevance therapeutics incHint incVeradermics inc

ImmPACT Bio Appoints Biren Amin, M B A to its Board of Directors

/PRNewswire/ ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR).

United statesSumant ramachandraBiren aminSheila gujrathiPrnewswire immpact bio united states incJefferies financial groupLong island universityPyramid biosciences incUniversity of sciencesAventis pharmaceuticalsImmuneering corporationBio united statesPyramid biosciencesWall streetStern schoolNew york university